Novavax Inc has made a bold move by submitting an application to the U.S. Food and Drug Administration (FDA) seeking authorization for the use of its COVID-19 vaccine as a booster dose. This means that individuals who have already received Novavax’s shots or a different vaccine may be eligible to receive an additional dose of the Novavax vaccine. It’s like when you’ve already had a delicious meal, but then someone offers you a mouthwatering dessert! The slow rollout of vaccines has created a pressing need for boosters to further enhance protection against the virus. With this request, Novavax aims to contribute to the ongoing efforts in curbing the spread of COVID-19 and preventing severe illness and hospitalizations. The potential authorization of Novavax’s vaccine as a booster could open up new avenues in our fight against the pandemic, as it would provide individuals with an added layer of defense. To learn more about the application and the science behind it, explore the full article!
